Hagen Heidi

Director | Interim CEO

2 companies

Hagen Heidi is a Director at Alaunos Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 1 sell.

Estimated insider holdings value: $1.6M based on current market prices.

Holdings by Company

TCRTSep 2, 2021

Current Shares145.9K

Value$315.1K

Net Activity+23.8K

Bought: 23.8KSold: 0

VCELApr 30, 2025

Current Shares31.9K

Value$1.29M

Net Activity-9,000

Bought: 0Sold: 9.0K

Showing 2 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M	SEC
Mar 3, 2025	VCEL Vericel Corp	Director	Sale+OE	9,000	$49.53	$445,770.00	-23.9%	-18.3%	-30.5%
Sep 2, 2021	TCRT Alaunos Therapeutics, Inc.	Director	Buy	23,770	$1.76	$41,835.20	+19.5%	-28.2%	+63.8%